Closed
SectorHealthcare
1.36 1.49
24h
Min
1.32
Max
1.4
Income | 206K -60M |
---|---|
EPS | -0.28 |
Profit margin | 272,450 |
Employees | 226 |
EBITDA | -302K -56M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +479.85% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | 53M 308M |
---|---|
Previous open | -0.13 |
Previous close | 1.36 |
By Acuity
50%
50%
164 / 381 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 7.77 USD 479.85%
High 14 USD
Low 2.5 USD
Based on 14 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$